Mark Walters
Chief Operating Officer at DARÉ BIOSCIENCE, INC.
Profile
Mark Walters was the founder of Daré Bioscience Operations, Inc. (founded in 2015) and held the title of Vice President-Operations & Projects.
He is currently working as Vice President-Operations at Daré Bioscience, Inc. Mr. Walters has previously worked as a Project Director at Alliance Pharmaceutical Corp.
from 1989 to 2001, Vice President-Commercial Development at SkyePharma Plc in 2007, Principal at Aventis, Inc., Senior Vice President-Technical Operations at Pacira Biosciences, Inc. from 2007 to 2012, and President at Walters Consulting Partners from 2012 to 2017.
He obtained his undergraduate degree from Hamilton College (New York).
Mark Walters active positions
| Companies | Position | Start |
|---|---|---|
| DARÉ BIOSCIENCE, INC. | Chief Operating Officer | 2014-12-31 |
Former positions of Mark Walters
| Companies | Position | End |
|---|---|---|
| Walters Consulting Partners | President | 2017-06-30 |
| PACIRA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2011-12-31 |
| SKYEPHARMA PLC | Corporate Officer/Principal | 2007-02-28 |
Alliance Pharmaceutical Corp.
 Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2000-12-31 |
Daré Bioscience Operations, Inc.
 Daré Bioscience Operations, Inc. Pharmaceuticals: MajorHealth Technology Part of Daré Bioscience, Inc., Daré Bioscience Operations, Inc. provides pharmaceutical products. The private company is based in La Jolla, CA. The company was founded by Lisa Walters-Hoffert, Mark Walters, Roger L. Hawley. Daré Bioscience Operations was acquired by Cerulean Pharma, Inc. on July 19, 2017 for $1.99 million. | Founder | - |
Training of Mark Walters
| Hamilton College (New York) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| DARÉ BIOSCIENCE, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Alliance Pharmaceutical Corp.
Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
| Aventis, Inc. | |
Whitehall Co Ltd
 Whitehall Co Ltd Food DistributorsDistribution Services Part of The United Group, Inc., Whitehall Co Ltd is a private company that distributes alcoholic beverages. The company is based in Norwood, MA. Whitehall Co was acquired by The United Group, Inc. on March 11, 2002. | Distribution Services |
Daré Bioscience Operations, Inc.
Daré Bioscience Operations, Inc. Pharmaceuticals: MajorHealth Technology Part of Daré Bioscience, Inc., Daré Bioscience Operations, Inc. provides pharmaceutical products. The private company is based in La Jolla, CA. The company was founded by Lisa Walters-Hoffert, Mark Walters, Roger L. Hawley. Daré Bioscience Operations was acquired by Cerulean Pharma, Inc. on July 19, 2017 for $1.99 million. | Health Technology |
| Walters Consulting Partners |
- Stock Market
- Insiders
- Mark Walters
